Ondissolve in the Prophylaxis/Rescue of Radiation Induced Nausea and Vomiting

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
NauseaVomiting
Interventions
DRUG

Ondansetron

Patients will take Ondissolve (8mg) on the day of the radiation treatment at least one hour prior to treatment and repeat approximately 6-8 hours later in the day (bid). For patients who are being treated with 20Gy in 5 fractions, or 30 Gy in 10 fractions, this group will take Ondissolve twice (bid) on each day of treatment, at least 1 hour prior to treatment and also on weekends or holidays in between treatment.

Trial Locations (1)

M4N 3M5

Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
collaborator

Takeda Canada, Inc.

INDUSTRY

lead

Sunnybrook Health Sciences Centre

OTHER

NCT02006056 - Ondissolve in the Prophylaxis/Rescue of Radiation Induced Nausea and Vomiting | Biotech Hunter | Biotech Hunter